Madelaine Niam

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

Y-C Linn, Madelaine Niam, Shu‐Hsun Chu et al. · Bone Marrow Transplantation · 2011 · 78 citations

Allogeneic Transplant, Cell Therapy, Transplantation +12

A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission

Yeh Ching Linn, Hao-Xiang Yong, Madelaine Niam et al. · Cytotherapy · 2012 · 45 citations

Hematological Malignancy, Radiation Oncology, Chronic Myeloid Leukemia +12

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies

Garnet Suck, Vincent Yi Sheng Oei, Yeh Ching Linn et al. · Experimental Hematology · 2011 · 36 citations

Cell Therapy, Cancer Immunosurveillance, Immunology +9

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

Emily Nickles, Bhushan Dharmadhikari, Yating Li et al. · Cancer Immunology Immunotherapy · 2021 · 28 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +9

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy

Madelaine Niam, Yeh Ching Linn, Stephanie Fook Chong et al. · Experimental Hematology · 2011 · 26 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Cell Therapy +13